Saito et al. noted that proteolytic degradation of vasohibin-1, a robust angiogenesis inhibitor, was enhanced in cancer cells [47], whereas calpains appeared to be stably activated, suggesting a mechanism for the reduction in vasohibin-1. The gene discussed is VASH1; the disease is cancer.